Study of STYLAGE® XXL for Volume Deficiency in the Mid-Face
NCT05355454 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2025-09-10
Summary
The primary objective of the study is to demonstrate the superiority of STYLAGE® XXL versus no treatment at 24 weeks after baseline for the creation or restoration of volume deficit in the mid-face.
Conditions
- Volume Deficiency in the Mid-Face
- Aging
- Aesthetics
Interventions
- DEVICE
-
STYLAGE® XXL
Up to 2.0 mL will be injected in the zygomaticomalar region and optionally up to 2.0 mL in the anteromedial cheek at the first session, on each side of the face. Up to 1.0 mL in the zygomaticomalar region and optionally up to 1.0 mL in the anteromedial cheek for the optional touch-up session, on each side of the face. Up to 2.0 mL will be injected in the zygomaticomalar region and optionally up to 2.0 mL in the anteromedial cheek before study exit, on each side of the face.
- DEVICE
-
STYLAGE® XXL
Up to 2.0 mL will be injected in the zygomaticomalar region and optionally up to 2.0 mL in the anteromedial cheek at the first session, on each side of the face. Up to 1.0 mL in the zygomaticomalar region and optionally up to 1.0 mL in the anteromedial cheek for the optional touch-up session, on each side of the face. Up to 2.0 mL will be injected in the zygomaticomalar region and optionally up to 2.0 mL in the anteromedial cheek before study exit, on each side of the face.
Sponsors & Collaborators
-
Avania B.V.
collaborator UNKNOWN -
Canfield Scientific Inc.
collaborator UNKNOWN -
Laboratoires Vivacy
lead INDUSTRY
Principal Investigators
-
Hervé RASPALDO, MD · Private Clinic, GENEVA, SWITZERLAND
-
Hugues CARTIER, MD · Centre Medical Saint-Jean, ARRAS, FRANCE
-
Thomas RAPPL, MD · Medical Aesthetic Research Academy, GRAZ, AUSTRIA
-
Cyril CLERICO, MD · Private Practice, NICE, FRANCE
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-06-06
- Primary Completion
- 2024-05-15
- Completion
- 2025-04-25
Countries
- France
Study Locations
More Related Trials
-
Study of a Novel Hyaluronic Acid Based Gel for Volume Deficiency in the Mid-face (FaceHyal)
NCT05747456 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of "LMW - CL - HA - FACE/BODY" for the Augmentation of the Cheeks
NCT06915402 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Safety and Effectiveness of STYLAGE® L for Correction of Moderate and Severe Nasolabial Folds in Chinese Adults
NCT04861766 ·Status: COMPLETED ·Phase: NA
-
Open Label, Multi-Center Study, Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Facial Fat Grafting
NCT05522426 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety and Efficacy of Juvederm® VOLUMA™ for Correction of Mid-face Volume Deficiency
NCT01029535 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies
NCT06351358 ·Status: COMPLETED ·Phase: NA
-
Autologous Facial Fat Grafting Study
NCT05482425 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Perlane-L in the Correction of Midface Volume Deficit
NCT01565915 ·Status: UNKNOWN ·Phase: NA
-
Canadian Aesthetic Experience With Sculptra Therapy
NCT00447551 ·Status: COMPLETED ·Phase: PHASE4
-
Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency
NCT04132518 ·Status: COMPLETED ·Phase: NA
-
HArmonyCa Injectable Gel for Mid Face Soft Tissue Augmentation
NCT05119777 ·Status: COMPLETED ·Phase: PHASE4
-
Histology Study of Biostimulatory Activity of Injectable Poly-L-Lactic Acid (Sculptra Aesthetic)
NCT04957446 ·Status: UNKNOWN ·Phase: NA
-
Volume Restoration of the Aging Midface With Sculptra Aesthetic
NCT01307865 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Performance of Princess® FILLER for the Treatment of Facial Lipoatrophy, Asymmetry or Scars
NCT03050723 ·Status: COMPLETED ·Phase: NA
-
The Volumizing Effect of Juvéderm VOLUMA® in the Mid-Face
NCT01559064 ·Status: COMPLETED
-
Injectable Filler for Cheek Flattening
NCT01225354 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Evaluation of the Safety and Performance of a Filler in Correction of Mid-face Age-related Volume Deficit
NCT04505319 ·Status: COMPLETED ·Phase: NA
-
A Restylane Treatment Algorithm Approach for Participants With Appearance of Insufficient Bone Structure in the Lower Face Alone or in Combination With Facial Soft Tissue Deficiencies
NCT06428214 ·Status: COMPLETED ·Phase: NA
-
Algeness DF 3.5% Compared to Voluma in Volume Deficit in Mid-face
NCT04892407 ·Status: UNKNOWN ·Phase: NA
-
Performance and Safety of the Lipo-transfer Cannulas in Patients Underlying Lipofilling Treatment
NCT06089759 ·Status: COMPLETED
-
Prospective Evaluation of Facial Cosmetic Procedures
NCT03460158 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Hyaluronic Acid Injectable Gel (VYC-25L) for Restoration and Creation of Facial Volume in the Chin and Jaw
NCT02559908 ·Status: COMPLETED ·Phase: NA
-
Midfacial Product Selection
NCT03381040 ·Status: COMPLETED ·Phase: PHASE4
-
Analysis of Safety and Tissue Interaction of Injectable and Energy-based Biosmulators
NCT06993558 ·Status: RECRUITING ·Phase: NA
-
Micro-injections of Transparent Hyaluronic Acid Gel (Restylane® Silk) for Rejuvenation of the Aging Cheek
NCT03461198 ·Status: UNKNOWN ·Phase: NA